Atricure Inc (ATRC) Company Profile & Statistics

Atricure Inc
ATRC
(Nasdaq - US)
Open
35.82
+0.09 (+0.24%)
in:usd•As of: Nov 25, 2024 09:39 UTC -5
Open
36.17
High
36.18
Low
35.82

About Atricure Inc

CEO

Michael H. Carrel

Headquarters

7555 innovation way

mason, oh 45040, united states

Auditor

Deloitte & Touche LLP

Employees

1,200

Share Holders

Website

www.atricure.com

Industry

medical specialties

Sector

health technology

Company Overview

AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a quivering of the upper chambers of the heart.

Atricure Inc Statistics

Valuation Measures

Market Capitalization ²	1.75B
Enterprise Value	1.68B
Enterprise Value/EBITDA (ttm)	-109.74
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	3.75
Price to Sales (ttm)	3.89
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	74.79%
Operating Margin (ttm)	-8.39%
Profit Margin (ttm)	-8.76%
Return on Equity (ttm)	-8.12%
Return on Invested Capital (ttm)	-7.35%
Return on Assets (ttm)	-6.21%

Income Statement

Revenue (ttm)	447.57M
Revenue Per Share (ttm)	9.18
Gross Profit (ttm)	334.72M
EBITDA (ttm)³	-15.31M
Net Income Avi to Common (ttm)	-38.92M
Diluted EPS (ttm)	-0.83

Share Statistics

Beta (5Y Monthly)	1.41
52-Week Change	-14.59%
S&P500 52-Week Change	31.90%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	48.75M
Dividend Yield	0.00%
Float ⁴	47.19M
% Held by Insiders	3.20%
% Held by Institutions	99.11%

Balance Sheet

Total Cash (mrq)	130.34M
Total Cash Per Share (mrq)	2.67
Total Debt (mrq)	64.58M
Total Debt/Equity (mrq)	13.89%
Current Ratio (mrq)	3.62%
Quick Ratio (mrq)	2.59%
Book Value Per Share (mrq)	9.54

Cash Flow

Operating Cash Flow Per Share (ytd)	0.14
Free Cash Flow (ytd)	-2.37M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Atricure Inc

Trade With A Regulated Broker